157 related articles for article (PubMed ID: 37756563)
1. PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Chen H; Bai Y; Kobayashi M; Xiao S; Barajas S; Cai W; Chen S; Miao J; Nguele Meke F; Yao C; Yang Y; Strube K; Satchivi O; Sun J; Rönnstrand L; Croop JM; Boswell HS; Jia Y; Liu H; Li LS; Altman JK; Eklund EA; Sukhanova M; Ji P; Tong W; Band H; Huang DT; Platanias LC; Zhang ZY; Liu Y
Mol Cancer Res; 2024 Jan; 22(1):94-103. PubMed ID: 37756563
[TBL] [Abstract][Full Text] [Related]
2. PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.
Chen H; Bai Y; Kobayashi M; Xiao S; Cai W; Barajas S; Chen S; Miao J; Meke FN; Vemula S; Ropa JP; Croop JM; Boswell HS; Wan J; Jia Y; Liu H; Li LS; Altman JK; Eklund EA; Ji P; Tong W; Band H; Huang DT; Platanias LC; Zhang ZY; Liu Y
Blood; 2023 Jan; 141(3):244-259. PubMed ID: 36206490
[TBL] [Abstract][Full Text] [Related]
3. PRL2/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal.
Kobayashi M; Bai Y; Dong Y; Yu H; Chen S; Gao R; Zhang L; Yoder MC; Kapur R; Zhang ZY; Liu Y
Stem Cells; 2014 Jul; 32(7):1956-67. PubMed ID: 24753135
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase of regenerating liver 2 (PRL2) deficiency impairs Kit signaling and spermatogenesis.
Dong Y; Zhang L; Bai Y; Zhou HM; Campbell AM; Chen H; Yong W; Zhang W; Zeng Q; Shou W; Zhang ZY
J Biol Chem; 2014 Feb; 289(6):3799-810. PubMed ID: 24371141
[TBL] [Abstract][Full Text] [Related]
5. BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid Leukemia.
Chen LT; Chen CT; Jiaang WT; Chen TY; Butterfield JH; Shih NY; Hsu JT; Lin HY; Lin SF; Tsai HJ
Mol Cancer Ther; 2016 Oct; 15(10):2323-2333. PubMed ID: 27512117
[TBL] [Abstract][Full Text] [Related]
6. Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
Vanderwinden JM; Wang D; Paternotte N; Mignon S; Isozaki K; Erneux C
Cell Signal; 2006 May; 18(5):661-9. PubMed ID: 15990278
[TBL] [Abstract][Full Text] [Related]
7. N822K- or V560G-mutated KIT activation preferentially occurs in lipid rafts of the Golgi apparatus in leukemia cells.
Obata Y; Hara Y; Shiina I; Murata T; Tasaki Y; Suzuki K; Ito K; Tsugawa S; Yamawaki K; Takahashi T; Okamoto K; Nishida T; Abe R
Cell Commun Signal; 2019 Sep; 17(1):114. PubMed ID: 31484543
[TBL] [Abstract][Full Text] [Related]
8. Protein Tyrosine Phosphatase PRL2 Mediates Notch and Kit Signals in Early T Cell Progenitors.
Kobayashi M; Nabinger SC; Bai Y; Yoshimoto M; Gao R; Chen S; Yao C; Dong Y; Zhang L; Rodriguez S; Yashiro-Ohtani Y; Pear WS; Carlesso N; Yoder MC; Kapur R; Kaplan MH; Daniel Lacorazza H; Zhang ZY; Liu Y
Stem Cells; 2017 Apr; 35(4):1053-1064. PubMed ID: 28009085
[TBL] [Abstract][Full Text] [Related]
9. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M
J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation.
Agarwal S; Kazi JU; Rönnstrand L
J Biol Chem; 2013 Aug; 288(31):22460-8. PubMed ID: 23803604
[TBL] [Abstract][Full Text] [Related]
11. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of KIT Oncogenic Signaling in Leukemia with Antibodies Targeting KIT Membrane Proximal Domain 5.
Le Gall M; Crépin R; Neiveyans M; Auclair C; Fan Y; Zhou Y; Marks JD; Pèlegrin A; Poul MA
Mol Cancer Ther; 2015 Nov; 14(11):2595-605. PubMed ID: 26358753
[TBL] [Abstract][Full Text] [Related]
13. PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia.
Carlock C; Bai Y; Paige-Hood A; Li Q; Nguele Meke F; Zhang ZY
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37665633
[TBL] [Abstract][Full Text] [Related]
14. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
[TBL] [Abstract][Full Text] [Related]
15. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).
Zeng S; Xu Z; Lipkowitz S; Longley JB
Blood; 2005 Jan; 105(1):226-32. PubMed ID: 15315962
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia.
Murray HC; Miller K; Brzozowski JS; Kahl RGS; Smith ND; Humphrey SJ; Dun MD; Verrills NM
Mol Cell Proteomics; 2023 Mar; 22(3):100503. PubMed ID: 36682716
[TBL] [Abstract][Full Text] [Related]
17. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.
Roberts KG; Smith AM; McDougall F; Carpenter H; Horan M; Neviani P; Powell JA; Thomas D; Guthridge MA; Perrotti D; Sim AT; Ashman LK; Verrills NM
Cancer Res; 2010 Jul; 70(13):5438-47. PubMed ID: 20551067
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N822K T>A mutation-induced constitutive c-KIT activation in AML cells triggers apoptotic and autophagic pathways leading to death.
Xu J; Zheng J; Fu X; Wu W; Tao L; Li D; Lin D
Int J Med Sci; 2019; 16(5):757-765. PubMed ID: 31217744
[No Abstract] [Full Text] [Related]
19. Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
Katagiri S; Chi S; Minami Y; Fukushima K; Shibayama H; Hosono N; Yamauchi T; Morishita T; Kondo T; Yanada M; Yamamoto K; Kuroda J; Usuki K; Akahane D; Gotoh A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563085
[TBL] [Abstract][Full Text] [Related]
20. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
Faderl S; Pal A; Bornmann W; Albitar M; Maxwell D; Van Q; Peng Z; Harris D; Liu Z; Hazan-Halevy I; Kantarjian HM; Estrov Z
Cancer Res; 2009 May; 69(9):3910-7. PubMed ID: 19383925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
